Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies

被引：5
|
作者：
El Ali, Ziad [1 ]
Rottey, Sylvie [2 ]
Barthelemy, Philippe [3 ]
Kotecki, Nuria [1 ,4 ]
Van Paemel, Ruben [2 ]
Devrient, Daniel [5 ]
Awada, Ahmad [1 ]
Gil, Thierry [1 ]
Pannier, Diane [4 ]
Ryckewaert, Thomas [4 ]
Waisse, Waissi [6 ]
Clavier, Jean-Baptiste [6 ]
Penel, Nicolas [4 ]
Vermassen, Tijl [2 ]
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, 121-125 Blvd Waterloo, Brussels, Belgium
[2] Ghent Univ Hosp, Dept Med Oncol, Ghent, Belgium
[3] Hopi Univ Strasbourg, Dept Med Oncol, Strasbourg, France
[4] Ctr Oscar Lambret, Dept Gen Oncol, Lille, France
[5] Inst Jules Bordet, Dept Radiotherapy, Brussels, Belgium
[6] Comprehens Canc Ctr Paul Strauss, Dept Radiat Oncol, Strasbourg, France
来源：
ANTICANCER RESEARCH | 2019年 / 39卷 / 06期
关键词：
Brain metastasis; renal cell carcinoma; survival; prognostic factors; PHASE-III; RADIATION-THERAPY; STEREOTACTIC RADIOSURGERY; SURVIVAL; EVEROLIMUS; SORAFENIB; PAZOPANIB; SYSTEMS; MODEL; TRIAL;
D O I：
10.21873/anticanres.13431
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: This study aimed at exploring several brain metastatic prognostic scores in patients with renal cell carcinoma. Patients and Methods: We retrospectively analyzed data of 93 metastatic renal cell carcinoma patients who were diagnosed with brain metastases between October 2005 and July 2016 who received targeted therapy. Potential prognostic factors (RTOG RPA, BS-BM, and a newly developed score CERENAL) were analyzed. Results: A total of 75 patients received targeted therapy. All scores showed prognostic value in progression-free survival after first-line treatment with CERENAL being the sole independent prognostic factor associated with improved duration of first-line treatment. Both RTOG RPA and CERENAL were potential prognosticators for overall survival, whereas only the CERENAL score was associated with prolonged disease-specific survival. Conclusion: Several prognostic scores can be useful to predict survival of patients with brain metastases from renal cancer, especially the newly developed CERENAL score.
引用
收藏
页码：2993 / 3002
页数：10
相关论文
共 50 条
  • [41] Prognostic value of toxicities induced by targeted therapies in patients treated for a metastatic renal cell carcinoma
    Nouhaud, F. X.
    Rebibo, J. -D.
    Blanchard, F.
    Sabourin, J. -C.
    Di Fiore, F.
    Pfister, C.
    PROGRES EN UROLOGIE, 2014, 24 (09): : 563 - 571
  • [42] Graded prognostic assessment index for renal cell carcinoma with brain metastases
    Garje, Rohan
    Dahiya, Saurabh
    Venur, Vyshak Alva
    Du, Lingling
    Osei-Boateng, Kwabena
    Elson, Paul
    Suh, John H.
    Chao, Samuel T.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Safety assessment of radiotherapy associated to targeted therapies in metastatic renal-cell carcinoma
    Rivoirard, R.
    Langrand-Escure, J.
    Vallard, A.
    Mery, B.
    Guy, J. B.
    Espenel, S.
    Trone, J. C.
    Ben Mrad, M.
    Diao, P.
    Guillot, A.
    Escudier, B.
    Negrier, S.
    Chargari, C.
    Magne, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S117 - S117
  • [44] Trends of Metastasis-Directed Treatments in Patients with Renal Cell Carcinoma: A Total Population-Based Analysis in Germany in the Era of Targeted Therapies
    Meyer, Christian P.
    Groeben, Christer
    Marks, Phillip
    Koch, Rainer
    Huber, Johannes
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12) : 679 - 685
  • [45] Safety and efficacy of targeted therapy for renal cell carcinoma (RCC) with brain metastasis.
    Bastos, Diogo Assed
    Molina, Ana M.
    Jia, Xiaoyu
    Velasco, Susanne
    Patil, Sujata
    Voss, Martin Henner
    Feldman, Darren Richard
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [46] Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy
    Roberto, Michela
    Bassanelli, Maria
    Antonio, Chiara D'
    Viterbo, Antonella
    Giacinti, Silvana
    Staddon, Anita
    Aschelter, Anna Maria
    Marchetti, Paolo
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (06) : 450 - 459
  • [47] Gastric Carcinoma at the Era of Targeted Therapies
    Dreanic, Johann
    Dhooge, Marion
    Sion, Elena
    Brezault, Catherine
    Chaussade, Stanislas
    Coriat, Romain
    CURRENT DRUG TARGETS, 2016, 17 (15) : 1818 - 1826
  • [48] Epidemiological trends in metastatic renal cell carcinoma in the era of targeted therapies: An analysis of the SEER registry.
    Rao, Arpit
    Wiggins, Charles
    Lauer, Richard C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [49] Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma
    Choi, Se Young
    Yoo, Sangjun
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : 717 - 723
  • [50] Brain metastasis from renal cell carcinoma
    Bennani, O.
    Derrey, S.
    Langlois, O.
    Castel, H.
    Laquerriere, A.
    Freger, P.
    Proust, F.
    NEUROCHIRURGIE, 2014, 60 (1-2) : 12 - 16
12345